Home A case report of generalized tetanus in a 42-year-old man with dental infection
Article
Licensed
Unlicensed Requires Authentication

A case report of generalized tetanus in a 42-year-old man with dental infection

  • Maria Ulfa EMAIL logo and Nuril Auliya Husna
Published/Copyright: December 7, 2019

Abstract

Background

In the post-vaccination era, as it is today, generalized tetanus is a rare diagnosis, although mortality and morbidity continue to increase significantly throughout the world. Infection occurs when the Clostridium tetani spores are introduced into wounds, skin lesions and infections. The symptoms often begin with stiffness or spasms in the jaw muscles; they are called trismus or “lockjaw” and/or then spread to the neck and abdominal muscles.

Case presentation

This is a report of a 42-year-old man who was referred to the hospital with dysphagia, rigidity and trismus. He was diagnosed with generalized tetanus with a Philips score of 15. The patient was admitted to the isolation unit, received treatment that included procaine penicillin, metronidazole, diazepam, human tetanus immunoglobulin (TIG) and anti-tetanus serum (ATS). Treatment was considered according to the guidelines of the World Health Organization, and also, the drug dose has no adverse event reaction during the treatment.

Conclusion

The therapeutic response is related to the identification and appropriate treatment, especially in hospitalized patients with inadequate immunization so that patients recover soon.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations and institutional policies, is in accordance with the tenets of the Helsinki Declaration (as revised in 2013).

References

[1] Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Disease. Chapter 16: Tetanus. Centers for Disease Control and Prevention National Center for Immunization and Respiratory Disease 2019, vol. 1:7, Atlanta: Centers for Disease Control and Prevention. 2017. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html. July 28 2019.Search in Google Scholar

[2] Sutiono AB, Qiantori A, Suwa H, Ohta T. Characteristic tetanus infection in disaster-affected areas: case study of the Yogyakarta earthquakes in Indonesia. BMC Res Notes 2009;2:34.10.1186/1756-0500-2-34Search in Google Scholar PubMed PubMed Central

[3] World Health Organization. WHO Communicable Diseases Working Group on Emergencies, Communicable Diseases Surveillance and Response and WHO Regional Office for the Americas. Current Recommendations for Treatment of Tetanus During Humanitarian Emergencies, 2010. WHO/HSE/GAR/DCE/2010. 2 2010 January; 4. https://www.who.int/diseasecontrol_emergencies/who_hse_gar_dce_2010_en.pdf. July 28 2019.Search in Google Scholar

[4] Sexton JD. Tetanus. https://www.uptodate.com/contents/tetanus, August 2018.Search in Google Scholar

[5] Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention website. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html 2017.Search in Google Scholar

[6] Aceh Epidemiology Group. Outbreak of tetanus cases following the tsunami in Aceh Province, Indonesia. Glob Public Health 2006;1:173–7.10.1080/17441690600652803Search in Google Scholar PubMed

[7] Afshar M, Raju M, Ansell D, Bleck TP. Narrative review: tetanus – a health threat after natural disasters in developing countries. Ann Intern Med 2011;154:329–35.10.7326/0003-4819-154-5-201103010-00007Search in Google Scholar PubMed

[8] WHO. 2019 global summary: incidence time series for Indonesia (IDN). Tetanus (total) Global Case: WHO vaccine-preventable diseases: monitoring system. Last update 15 July 2019. https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencettetanus.html. 2015. Oct 05 2019.Search in Google Scholar

[9] Ministry of Health Republic of Indonesia. 2015 Indonesia Health Profile: Chapter V Health of Indonesian Families: Annex 5.12 and Annex 5.13. Jakarta: Ministry of Health of Repubic Indonesia. http://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/indonesian%20health%20profile%202015.pdf 2016 August978-602-235-911-1. Oct 05 2019.Search in Google Scholar

[10] Wadiah AA, Mohammed AS, Mohammed AA, Nazeh EF. Severe generalized tetanus: a case report and literature review. Saudi J Med Medical Sci 2015;3:167–9.10.4103/1658-631X.156437Search in Google Scholar

[11] Darraj M, Stone J, Keynan Y, Thompson K, Snider C. A case of tetanus secondary to an odontogenic infection. Can J Emerg Med 2017;19:497–9.10.1017/cem.2016.390Search in Google Scholar PubMed

[12] Chaturaka R, Deepika F, Senaka R. Pharmacological management of tetanus: an evidence-based review. Crit Care Mar 2014;18:10.10.1186/cc13797Search in Google Scholar

[13] Leman MM, Tumbelaka RA. Penggunaan anti tetanus serum dan human tetanus immunoglobulin pada tetanus anak, laporan kasus. Sari Pediatri Des 2010;12:283–8.10.14238/sp12.4.2010.283-8Search in Google Scholar

Received: 2019-09-17
Accepted: 2019-10-27
Published Online: 2019-12-07

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0243/html
Scroll to top button